Meet with Crystec at CPhI Worldwide, November 2019
CrystecPharma are attending CPhI in Frankfurt in November, where CEO, Paul Thorning, will participate on the pane of “The Future of Medicine: What are the therapies of tomorrow?”. Contact us today to schedule a meeting at the event, to learn more about how we could help you to improve product performance and accelerate development timelines.
Are you attending CPhI Worldwide in Frankfurt, Germany, from 5th - 7th November? Crystec will be there and would love to meet you!
Crystec’s CEO, Paul Thorning, will take part in a panel discussion during the event, “The Future of Medicine: What are the therapies of tomorrow?” The panel will examine emerging therapies for the future pharma toolkit –both developing the new and repurposing the old. Come along to the CPhI Theatre (61D61) at 10:30 on Tuesday 5th November, where Paul will be joined by representatives of IQVIA, Camargo Pharmaceutical Services, Strategy& and KSBL.
If you are facing solubility, bioavailability, stability or other product development challenges, and would like to discuss how Crystec's mSAS® (modified Supercritical Anti-Solvent) technology could provide a solution, please contact Emily Bevis (firstname.lastname@example.org) to schedule a meeting.
Wir sehen uns in Frankfurt!
For more information about the event visit www.cphi.com/europe/.